Triple-negative breast cancer (TNBC) is a subtype of BC that does not express estrogen receptor (ER), progesterone receptor (PR), or human epidermal growth factor receptor 2 (HER-2), and, therefore, is not sensitive to endocrine therapy or HER2 treatment [119]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.